EG20539A - Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure - Google Patents

Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure

Info

Publication number
EG20539A
EG20539A EG68994A EG68994A EG20539A EG 20539 A EG20539 A EG 20539A EG 68994 A EG68994 A EG 68994A EG 68994 A EG68994 A EG 68994A EG 20539 A EG20539 A EG 20539A
Authority
EG
Egypt
Prior art keywords
hydrogen
pct
blood pressure
chloro
methyl
Prior art date
Application number
EG68994A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of EG20539A publication Critical patent/EG20539A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
EG68994A 1993-11-05 1994-11-02 Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure EG20539A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303657A SE9303657D0 (sv) 1993-11-05 1993-11-05 Short-acting dihydropyridines

Publications (1)

Publication Number Publication Date
EG20539A true EG20539A (en) 1999-07-31

Family

ID=20391655

Family Applications (1)

Application Number Title Priority Date Filing Date
EG68994A EG20539A (en) 1993-11-05 1994-11-02 Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure

Country Status (36)

Country Link
US (1) US5856346A (pl)
EP (1) EP0726894B1 (pl)
JP (1) JP3712209B2 (pl)
KR (1) KR100331663B1 (pl)
CN (1) CN1049428C (pl)
AT (1) ATE194330T1 (pl)
AU (1) AU685532B2 (pl)
BR (1) BR9407946A (pl)
CA (1) CA2174969C (pl)
CZ (1) CZ285691B6 (pl)
DE (1) DE69425152T2 (pl)
DK (1) DK0726894T3 (pl)
EE (1) EE03230B1 (pl)
EG (1) EG20539A (pl)
ES (1) ES2150544T3 (pl)
FI (1) FI110429B (pl)
FR (1) FR12C0053I2 (pl)
GR (1) GR3034469T3 (pl)
HK (1) HK1013292A1 (pl)
HU (1) HU215591B (pl)
IL (1) IL111127A (pl)
IS (1) IS1674B (pl)
LU (1) LU92209I2 (pl)
MY (1) MY111770A (pl)
NO (1) NO305656B1 (pl)
NZ (1) NZ275915A (pl)
PL (1) PL185099B1 (pl)
PT (1) PT726894E (pl)
RU (1) RU2139278C1 (pl)
SA (1) SA94150250B1 (pl)
SE (1) SE9303657D0 (pl)
SK (1) SK281467B6 (pl)
TW (1) TW279859B (pl)
UA (1) UA45959C2 (pl)
WO (1) WO1995012578A1 (pl)
ZA (1) ZA947570B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
CA2467759C (en) * 2001-12-21 2012-04-03 Alcon, Inc. Use of nanoparticles as carriers for biocides in ophthalmic compositions
FR2922439B1 (fr) * 2007-10-18 2010-12-10 Hill Rom Ind Sa Procede de gonflage alterne d'un dispositif de support a cellules gonflables et dispositif pour sa mise en oeuvre
PL2320740T3 (pl) 2008-08-01 2014-09-30 The Medicines Co Kompozycje farmaceutyczne klewidypiny oraz sposoby ich wytwarzania z niskim stężeniem zanieczyszczeń
KR101644286B1 (ko) * 2009-09-30 2016-08-10 마이크로도스 테라퓨특스, 인코포레이티드 레이노 증후군의 치료를 위한 방법들 및 조성물들
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
CA2701087A1 (en) * 2010-04-12 2011-10-12 Alphora Research Inc. Preparation of clevidipine butyrate ring the same
US8455655B2 (en) 2010-05-07 2013-06-04 Laboratorios Lesvi, S.L. Preparation of dihydropyridines
ES2571043T3 (es) 2010-05-07 2016-05-23 Lesvi Laboratorios Sl Preparación de dihidropiridinas
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
HUE026295T2 (en) 2010-10-12 2016-06-28 The Medicines Co Clevidipine emulsion formulations containing antimicrobial agents
CN103781479A (zh) * 2011-04-01 2014-05-07 医药公司 用于减轻中风损害的短效二氢吡啶（氯维地平）
AU2012303683B2 (en) 2011-08-26 2016-09-08 Wockhardt Limited Methods for treating cardiovascular disorders
CN103420899B (zh) * 2012-05-25 2016-01-27 四川科伦药物研究有限公司 一种丁酸氯维地平的纯化方法
EA030354B1 (ru) 2012-10-26 2018-07-31 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способ уменьшения диспноэ у пациента с острой сердечной недостаточностью
CN103086956B (zh) * 2013-01-17 2015-11-04 北京嘉林药业股份有限公司 一种丁酸氯维地平中间体的纯化方法
CN103073485B (zh) * 2013-01-17 2015-09-02 北京嘉林药业股份有限公司 一种丁酸氯维地平的制备方法
MX2016015208A (es) 2014-05-19 2017-03-23 The Medicines Co Nanoparticulas de clevidipina y composiciones farmaceuticas que las contienen.
CN105367487A (zh) * 2014-08-23 2016-03-02 南京海纳医药科技有限公司 一种丁酸氯维地平重要中间体新的合成方法
CN104370802A (zh) * 2014-09-24 2015-02-25 北京蓝丹医药科技有限公司 氯维地平衍生物及其制备方法
SG10202103403SA (en) 2015-05-20 2021-05-28 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic depsipeptide compounds
SG11201805368YA (en) 2015-12-28 2018-07-30 Merial Inc Anthelmintic depsipeptide compounds
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
RU2755349C1 (ru) * 2021-02-16 2021-09-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Применение бензил 6-({ 2-[(3,4-диметилфенил)амино]-2-оксоэтил} тио)-2-метил-4-(4-хлорфенил)-5-циано-1,4-дигидропиридин-3-карбоксилата в качестве гепатопротекторного средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
US5134139A (en) * 1989-08-31 1992-07-28 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and preparation thereof
JPH0641075A (ja) * 1990-09-01 1994-02-15 Kazuo Achinami 新規な１，４−ジヒドロピリジン化合物及びその製造方法

Also Published As

Publication number Publication date
US5856346A (en) 1999-01-05
HU215591B (hu) 1999-01-28
UA45959C2 (uk) 2002-05-15
AU8119694A (en) 1995-05-23
FI110429B (fi) 2003-01-31
PL314128A1 (en) 1996-08-19
NO961776D0 (no) 1996-05-02
DK0726894T3 (da) 2000-10-23
FI961914A0 (fi) 1996-05-06
IL111127A0 (en) 1994-12-29
GR3034469T3 (en) 2000-12-29
CN1049428C (zh) 2000-02-16
KR100331663B1 (ko) 2002-09-26
CZ285691B6 (cs) 1999-10-13
WO1995012578A1 (en) 1995-05-11
CA2174969A1 (en) 1995-05-11
JPH09504542A (ja) 1997-05-06
SK281467B6 (sk) 2001-04-09
IS1674B (is) 1997-12-31
CN1137269A (zh) 1996-12-04
HK1013292A1 (en) 1999-08-20
NO961776L (no) 1996-05-02
ATE194330T1 (de) 2000-07-15
FR12C0053I1 (pl) 2012-02-11
CZ127396A3 (en) 1996-09-11
AU685532B2 (en) 1998-01-22
IS4218A (is) 1995-05-06
EP0726894A1 (en) 1996-08-21
ZA947570B (en) 1995-05-29
ES2150544T3 (es) 2000-12-01
TW279859B (pl) 1996-07-01
PT726894E (pt) 2000-10-31
HUT75316A (en) 1997-05-28
SA94150250B1 (ar) 2006-03-01
JP3712209B2 (ja) 2005-11-02
BR9407946A (pt) 1996-11-26
DE69425152D1 (de) 2000-08-10
HU9601187D0 (en) 1996-07-29
NO305656B1 (no) 1999-07-05
NZ275915A (en) 1997-04-24
PL185099B1 (pl) 2003-02-28
SE9303657D0 (sv) 1993-11-05
SK55996A3 (en) 1996-12-04
RU2139278C1 (ru) 1999-10-10
FR12C0053I2 (fr) 2013-08-16
MY111770A (en) 2000-12-30
IL111127A (en) 2000-11-21
EE03230B1 (et) 1999-10-15
LU92209I2 (fr) 2013-08-23
FI961914A (fi) 1996-05-06
CA2174969C (en) 2005-05-17
EP0726894B1 (en) 2000-07-05
DE69425152T2 (de) 2001-03-22

Similar Documents

Publication Publication Date Title
EG20539A (en) Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure
GR3030491T3 (en) Hypolipidaemic benzothiazepine compounds.
NZ238206A (en) The stereoselective preparation of phenylisoserine derivatives and the use of such derivatives in preparing baccatin-iii and 10-deacetylbaccatin-iii derivatives
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
GR3017766T3 (en) Process for preparing sertraline.
HUT64309A (en) Process for production pharmaceutical preparations having benzazepine compounds as effective substance and the new effective substance
IL113002A0 (en) 4 - methylene - 2H - chromen - 3(4H)- one derivatives their preparation and use
GB9306899D0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
ES8207519A1 (es) Procedimiento para la obtencion de derivados del imidazol.
HUT75343A (en) Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing the said compds.
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
ATE96803T1 (de) Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ES8307798A1 (es) Un procedimiento para la preparacion de derivados de piperazilmetil-4-dibenzofuranona, o, dibenzofuranol.